A feedlot growth-performance trial and a metabolism trial were conducted to evaluate a dose response to ardacin (a glycopeptide antibiotic). Treatments consisted of an 88% concentrate finishing diet supplemented to contain (DM basis) 0, 8.25, 16.5, or 33 mg ardacin/kg. The growth-performance trial (129 d) involved 120 heifers and 120 steers in a randomized complete block design. There were no interactions (P > .lo) between sex and response to ardacin. Average daily gain increased (P < .OS) and DM conversion decreased (P < .01) with increasing levels of ardacin supplementation. At the 33 mg/kg level of supplementation, ADG and DM conversion were improved 10.6 and 5.6%, respectively.
Introduction
Ardacin is a glycopeptide antibiotic produced by Kibdelosporangiwn aridum (A~W-216)~. It is effective against a broad spectrum of Gram-positive bacteria (Grappel et al., 1985) . The antimicrobial properties of glycopeptide antibiotics are thought to be primarily directed at inhibition of muramylpentapeptideacetylglucosamine transfer from the lipid carrier to the peptidoglycan chain during cell wall synthesis (Lancini and Parenti, 1982) . However, very little has been reported regarding the specific antimicrobial properties of ardacin, and no studies have been reported evaluating the effectiveness of ardacin as a feed additive for enhancing cattle performance. Supplementation of fishing diets with avoparcin, which is also a glycopeptide antibiotic, has improved ADG and feed conversion in feedlot cattle (Johnson et al., 1979; al., 1980; Owens and G i l l , 1981). As with the ionophores, supplementation with avoparch has resulted in decreased ruminal molar concentrations of acetate and increased concentrations of propionate (Johnson et al., 1979) . However, the VFA response to supplementation has been inconsistent (Dyer et d., 1980) . The objective of the present trial was to evaluate the dose response to ardacin supplementation on feedlot cattle growth performance and characteristics of ruminal and total tract digestion.
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Experimental Procedures
Triul I. One hundred twenty crossbred (approximately 25% Brahman blood with the remainder represented by Hereford, Angus, Shorthorn, and Charolais breeds in various proportions) heifers (292 kg) and steers (330 kg) were used in this trial. Heifers were treated with fenpro~talene~ (abortifacient) 56 d before initiating the feeding trial. Twenty days before initiating the trial, steers and heifers were blocked by sex and weight and randomly assigned to 48 pens (five steers or heifers/pen). Pens were equipped with automatic waterers and fence-lined feed bunks. During this adjustment period all cattle received the basal (unsupplemented) diet. Composition of the basal diet is shown in Table 1 After the carcasses were chilled for 48 h, the following measurements were obtained: 1) longissimus muscle area (ribeye area), taken by direct grid reading of the eye muscle at the 12th rib 2) subcutaneous fat over the eye muscle at the 12th rib, taken at a location 3/4 the lateral length from the chine bone end (adjusted by eye for unusual fat distribution);
3) kidney, pelvic, and heart fat (KPH) as a percentage of carcass weight; and 4) marbling score (USDA, 1965) . The trial was analyzed as a randomized complete block design experiment (Hicks, 1973 ). Treatment effects were tested for linear, quadratic, and cubic components by means of orthogonal polynomials established for unequal (0, 1, 2, 4) treatment spacing (Little and Hill, 1978) .
Trial 2. Four Holstein steers (344 kg) with cannulas in the rumen and proximal duodenum (6 cm from the pyloric sphincter) were used to evaluate treatment effects on characteristics of digestion. Composition of the basal diet is shown in Table 1 . A single chromic oxide premix containing all dietary ingredients minus 6.9% of the corn was prepared (this corresponded to 95% of the total diet DM). Using ground corn as a carrier, the respective ardacin treatment premixes (5% of total feed allotment, as-fed basis) were combined with the basal diet premix (95% of total feed allotment, asfed basis) at the time of feeding. Dry matter intake was restricted to 5.27 kg/d. Diets were fed at 0800 and 2000 daily. Following a 10-d diet adjustment period, duodenal and fecal samples were taken from all steers twice daily over a period of four successive days as follows: d 1, .0750 and 1350; d 2, 0900 and 1500; d 3, 1050 and 1650; and d 4, 1200 and 1800. Individual samples consisted of approximately 500 ml of duodenal chyme and 200 g (wet basis) of fecal material. Samples from each steer and within each period were composited for analysis. During the final day of each collection period, ruminal samples were obtained from each steer at approximately 4 h after feeding. Ruminal fluid pH was determined and, subsequently, 2 ml of freshly prepared 25% (wt/vol) metaphosphoric acid was added to 8 ml of strained ruminal fluid. Samples were then centrifuged (1 7,000 x g for 10 min) and supernatant fluid was stored at -20°C for VFA analysis. Samples were subjected to all or part of the following analysis: DM (oven drying at 105'C until there was no further weight loss); ash, Kjeldahl N, ammonia N (AOAC, 1975) ; purines ( Z i n n and Owens, 1986) ; VFA concentrations of ruminal fluid (gas chromatography using 10% SP-1200/1% HpO4 on SO/lOO Chromosorb W AW packing in a 183-cm x 2-mm i.d. glass column with column, inlet, and detector temperatures maintained at 120, 195, and 2WC, respectively, and with a carrier gas WfJ flow rate at 20 ml/ min); chromic oxide (Hill and Anderson, 1958) ; and starch (Zinn, 1990) . Microbial OM (MOM) and N (MN) leaving the abomasum was calculated using purines as a microbial marker ( Z i n n and Owens, 1986) . Organic matter fermented in the rumen ( O W ) was considered equal to OM intake minus the difference between the amount of total OM reaching the duodenum and MOM reaching the duodenum. Feed N escape to the small intestine was considered equal to total N leaving the abomasum minus ammonia N and MN and, thus, included any endogenous contributions. The trial was analyzed as a 4 x 4 Latin square design experiment (Hicks, 1973 ). Treatment effects were tested for linear, quadratic, and cubic components by means of orthogonal polynomials established for unequal treatment spacing (Little and Hills, 1978) .
Results and Discussion
Trial 1 was conducted during the months of April through August of 1989. Average minimum and maximum daily temperatures during Trial 1 were 18.9 and 38.9'C, respectively. Average minimum and maximum daily relative humidities were 29 and 62%, respectively. There was no precipitation during the trial. ADG by an average of 4.3%. At the 33 m a g dosage level ADG was increased 10.6% over the control. Improvements in DM conversion were more nearly linear with ardacin dosage level, averaging 1.1, 3.2, and 5.6%. respectively. Estimated diet NE, and NEg were similar for the 0 and 8.25 mg ardacWg dosage levels. At the 16.5 and 33.0 mg/kg levels, estimated NE, was increased 1.8 and 2.6%. respectively. Corresponding diet NEg values were increased 2.5 and 3.8%, respectively. Dry matter intake tended to be increased (cubic effect, P < .lo) with ardacin supplementation.
Maximum numerical increase (4.5%) was observed at the 33 mgkg dosage.
The NE estimates for maintenance and gain shown in Table 2 were determined assuming a constant energy requirement for maintenance (.077 Wkg.75). An alternative approach for expressing ardacin effects on animal energetics is to let the NE value of the diet remain constant and present treatment effects solely as a function of changes in maintenance coefficient (Zinn, 1986) . In this manner, the Table 2 ). The remaining 11% is more directly related to ardacin effects on energy intake above maintenance. The influences of ardacin dosage level on carcass traits are shown in Table 3 . There was no treatment effect (P > .lo) on dressing percentage, rib eye area, KPH, marbling score, or liver abscesses. The incidence of liver abscesses was low across treatments, averaging 2% (livers from five steers and one heifer were abscessed). There were cubic effects of ardacin dosage level on fat thickness (P< .lo) and retail yield (P e .05). Fat thickness and retail yield tended to be lower at the 8.25 and 33.0 m a g levels than at the 0 and 16.5 m a g levels. The basis for this is unknown. 'Cubic effect, P < .lo. dKidney, pelvic, and heart fat as a percentage of carcass weight. eCoded: Minimum slight = 3, minimum small = 4, etc. kubic effect, P < .OS.
There are no studies reported thus far that can be compared directly with the results of Trial 1. However, several trials have been conducted evaluating avoparcin, which along with ardacin belongs to the glycopeptide family of antibiotics. Johnson et al. (1979) evaluated the effects of 0, 16.5, 33, and 66 mg avoparcin/kg and 33 monensin/kg in a finishing diet for feedlot steers. In that trail, avoparcin at the 33 and 66 mg/kg levels of supplementation increased ADG 8.1% and DM conversion 7.6%. Average daily gain and DM conversion were not different between steers supplemented with monensin and unsupplemented controls. Dyer et al. (1980) evaluated the effects of 0, 33, 49.5, and 66 mg avoparcin/kg in a finishing diet for feedlot heifers. They did not observe a treatment response in ADG. However, DM conversion was increased 4.3% across avoparcin supplementation levels. Carcass merit was not influenced by avoparcin supplementation. In a 112-d finishing trial comparing avoparcin (66 m a g ) and monensin (33 m a g ) vs an unsupplemented control, Owens and Gill (1981) observed similar improvements (5.7%) in DM conversion for avoparcin and monensin. However, ADG tended to be lower (4.1%) for avoparcin than for monensin and the unsupplemented controls. Avoparcin supplementation decreased marbling score (9.2%) and tended to increase fat thickness.
The influences of ardacin supplementation on characteristics of ruminal and total tract digestion (Trial 2) are shown in Table 4 . There were linear and cubic effects (P < .05) on ruminal digestion of starch. At the 16.5 and 33.0 mg/kg levels of supplementation, ruminal digestion of starch was increased 5.8 and 3.9%, respectively. There was a cubic effect (P c .lo) of ardacin supplementation on MN synthesis. At the 8.25 m@g level, MN synthesis tended to be slightly higher (6.2%) than in the control. However, at the 16.25 and 33.0 m a g levels, MN synthesis was decreased (16.6 and 9.2%, respectively). There were linear (P e .lo) and cubic (P e .OS) effects of ardacin supplementation on microbial efficiency (grams of MNMogram of OM fermented). At the 16.5 and 33.0 m a g levels of supplementation there was a tendency for less (20.8 and 10.4%, respectively) MN synthesis per unit of OM fermented. There was also a tendency (P > .lo) for decreased ruminal degradation of feed N at the 16.5 and 33.0 m@g levels of supplementation.
Total tract digestion of OM, starch, and ADF was not affected (P > .lo) by ardacin supplementation. There was a linear component to total tract N digestion. At the 16.5 and 33.0 m@g levels of supplementation apparent N digestibility was increased (5.3%).
The effects of ardacin supplementation on microbial synthesis and ruminal degradation of feed N are similar to responses observed with ionophore antibiotics (Schelling, 1984) . The increase in apparent total tract N digestibility observed with ardacin supplementation also has been a response to ionophore antibiotic supplementation (Poos et al., 1979; Patterson et al., 1983; Zinn, 1987) and is probably a reflection of the decreased MN synthesis.
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The influences of &in supplementation were quite variable; consequently, no statistion ruminal pH, VFA profiles, and estimated cally significant (P > .lo) treatment effects on methanogenesis are shown i n associated with a linear decrease (P e .05) in ruminal VFA concentrations. The 0 and 8.25 m a g treatments were similar, however, with the 16.5 and 33.0 m a g treatments, and total mM VFA concentrations were decreased 19.3 and 28.3%, respectively. Because there were no treatment effects on ruminal OM digestion (P > .lo), it seems that ardacin supplementation may be acting to increase ruminal dilution.
In terms of ruminal VFA molar proportions (mo1/100 mol of VFA), only isovalerate was affected (linear and quadratic components, (P < .lo) by ardacin treatments. At the 33.0 mg/ kg level of supplementation. the molar proportion of isovalerate was 46% that of the unsupplemented control. This decrease in molar proportions of isovalerate with ardacin supplementation is a reflection of the effects of ardacin on ruminal feed N degradation.
The influence of avoparcin on molar proportions of ruminal VFA has not been consistent. Johnson et al. (1979) observed a 40% decrease in acetate:propionate ratios with avoparcin supplementation of a fishing diet at the rate of 66 m a g . However, at lower levels of supplementation (16.5 and 33 m a g ) treatment effects were small. Furthermore, monensin (33 m a g ) supplementation did not influence acetate:propionate ratios. Dyer et al.
(1980) observed a tendency for decreased (18.5%) acetate:propionate ratios at the 66 mg/ kg level of supplementation. However, at the 33 m a g level of supplementation the molar ratios of acetate and propionate were not different from the control. The basis for the variable responses among trials in ruminal VFA is not certain. It seems that level of supplementation may be a factor.
Implications
It is concluded that supplementation of a finishing diet with 33 mg ardacin/kg (dry matter basis) will improve average daily gain and dry matter conversion. The improvement in dry matter conversion can largely (89%) be explained on the basis of increased net energy of the diet (3.2%) or decreased maintenance requirement (8.6%). Because ruminal molar proportions of volatile fatty acids and site and extent of organic matter digestion were not influenced by ardacin supplementation, the primary cause of improved energetics is most likely a decreased maintenance requirement.
